Loading...
Home Page 2017-11-15T16:25:11+00:00

The Future of Healthcare

Humans have spent centuries looking for new ways to help extend and increase the well-being of their lives for the present and future generations. With the advancement in molecular and developmental cell biology, the power of true healing is being revealed within ourselves.

Human Cell and Tissue Products

Research has shown that the use of human cell and tissue products from umbilical cord and other birth tissues could potentially have a disruptive affect on the way certain injuries and human ailments are managed.

Proprietary Processing

Predictive utilizes advanced tissue processing techniques to manufacture human cell and tissue allografts.  Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested in accordance with standards established by FDA requirements.

Quality and Experience

Predictive’s team of research scientist and technicians have decades of experience with tissue processing and cell biology.  We are working tirelessly to convert the latest and greatest scientific discoveries into innovative products for regenerative medicine.

Learn More

Predictive Biotech a leading provider of human cell and tissue products

Our flagship allograft CoreCyte™ is processed to maintain the cushioning and protective integrity of Wharton's Jelly.
Learn More

Products

AmnioCyte™ is a minimally manipulated human tissue allograft derived from amniotic fluid. AmnioCyte™ is processed to preserve the cytokines, growth factors and proteins in amniotic fluid for homologous use.

AmnioCyte Plus™ is a minimally manipulated human tissue allograft derived from the extracellular matrix of the amniotic membrane.  AmnioCyte Plus™ is processed to preserve cytokines, growth factors and scaffolding proteins in amniotic membrane for homologous use.

PolyCyte™ is a minimally manipulated human tissue allograft derived from the Wharton’s Jelly of the umbilical cord. PolyCyte™ is processed to preserve cytokines, growth factors, proteins and structural integrity of Wharton’s jelly for homologous use.

CoreCyte™ is a minimally manipulated human tissue allograft derived from the Wharton’s Jelly of the umbilical cord. CoreCyte™ is processed to preserve the structural integrity of Wharton’s jelly for homologous use and cryogenically preserved.

CoreCyte™, PolyCyte™, AmnioCyte Plus™ and AmnioCyte™ are processed from donated human tissue from full term deliveries and is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

Follow us for updates and news!